Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery - PubMed (original) (raw)
. 2007 Oct;27(10):2113-9.
doi: 10.1161/ATVBAHA.107.147322. Epub 2007 Aug 23.
Annemarie E Silver, Elena Shvenke, David W Schopfer, Eiman Jahangir, Megan A Titas, Alex Shpilman, James O Menzoian, Michael T Watkins, Joseph D Raffetto, Gary Gibbons, Jonathan Woodson, Palma M Shaw, Mandeep Dhadly, Robert T Eberhardt, John F Keaney Jr, Noyan Gokce, Joseph A Vita
Affiliations
- PMID: 17717291
- PMCID: PMC2596307
- DOI: 10.1161/ATVBAHA.107.147322
Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery
Alex L Huang et al. Arterioscler Thromb Vasc Biol. 2007 Oct.
Abstract
Objective: Reactive hyperemia is the compensatory increase in blood flow that occurs after a period of tissue ischemia, and this response is blunted in patients with cardiovascular risk factors. The predictive value of reactive hyperemia for cardiovascular events in patients with atherosclerosis and the relative importance of reactive hyperemia compared with other measures of vascular function have not been previously studied.
Methods and results: We prospectively measured reactive hyperemia and brachial artery flow-mediated dilation by ultrasound in 267 patients with peripheral arterial disease referred for vascular surgery (age 66+/-11 years, 26% female). Median follow-up was 309 days (range 1 to 730 days). Fifty patients (19%) had an event, including cardiac death (15), myocardial infarction (18), unstable angina (8), congestive heart failure (6), and nonhemorrhagic stroke (3). Patients with an event were older and had lower hyperemic flow velocity (75+/-39 versus 95+/-50 cm/s, P=0.009). Patients with an event also had lower flow-mediated dilation (4.5+/-3.0 versus 6.9+/-4.6%, P<0.001), and when these 2 measures of vascular function were included in the same Cox proportional hazards model, lower hyperemic flow (OR 2.7, 95% CI 1.2 to 5.9, P=0.018) and lower flow-mediated dilation (OR 4.2, 95% CI: 1.8 to 9.8, P=0.001) both predicted cardiovascular events while adjusting for other risk factors.
Conclusions: Thus, lower reactive hyperemia is associated with increased cardiovascular risk in patients with peripheral arterial disease. Furthermore, flow-mediated dilation and reactive hyperemia incrementally relate to cardiovascular risk, although impaired flow-mediated dilation was the stronger predictor in this population. These findings further support the clinical relevance of vascular function measured in the microvasculature and conduit arteries in the upper extremity.
Figures
Figure 1
Kaplan–Meier plots showing survival according to tertile of hyperemic velocity. Overall, survival differed according to tertile of hyperemic velocity by log-rank test (_P_=0.03). By pairwise comparison, the survival curves for the lower (8 to 61 cm/sec, n=89) and middle (63 to 105 cm/sec, n=89) tertiles did not differ (_P_=0.91), but both differed from the highest tertile (105 to 269 cm/sec, n=89) by log-rank test (_P_=0.01 for both).
Figure 2
Kaplan–Meier plots showing survival according to tertile of flow-mediated dilation. Overall, survival differed according to tertile of flow-mediated dilation by log-rank test (P<0.001). By pairwise comparison, the survival curves for the lower (−2.3 to 4.1%, n=89) and middle (4.2 to 7.9%, n=89) tertiles did not differ (_P_=0.34), but both differed from the highest tertile (8.0% to 25%, n=89) by log-rank test (P<0.001 and _P_=0.002, respectively).
Comment in
- Reactive hyperemia and cardiovascular risk.
Philpott A, Anderson TJ. Philpott A, et al. Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2065-7. doi: 10.1161/ATVBAHA.107.149740. Arterioscler Thromb Vasc Biol. 2007. PMID: 17881738 No abstract available. - Reactive hyperemia revisited.
Calderaro D, Monachini MC, Vieira CL, Yu PC, Gualandro DM, Marques AC, Caramelli B. Calderaro D, et al. Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):e23-4; author reply e25. doi: 10.1161/ATVBAHA.107.158931. Arterioscler Thromb Vasc Biol. 2008. PMID: 18354086 No abstract available. - Commentary. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery.
Bekelis K, Labropoulos N. Bekelis K, et al. Perspect Vasc Surg Endovasc Ther. 2008 Jun;20(2):224-6. doi: 10.1177/1531003508319221. Perspect Vasc Surg Endovasc Ther. 2008. PMID: 18644817 No abstract available.
Similar articles
- Reactive hyperemia and cardiovascular risk.
Philpott A, Anderson TJ. Philpott A, et al. Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2065-7. doi: 10.1161/ATVBAHA.107.149740. Arterioscler Thromb Vasc Biol. 2007. PMID: 17881738 No abstract available. - Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease.
Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Vita JA. Gokce N, et al. J Am Coll Cardiol. 2003 May 21;41(10):1769-75. doi: 10.1016/s0735-1097(03)00333-4. J Am Coll Cardiol. 2003. PMID: 12767663 - Interleukin-6 and interleukin-10 gene polymorphism, endothelial dysfunction, and postoperative prognosis in patients with peripheral arterial disease.
Stoica AL, Stoica E, Constantinescu I, Uscatescu V, Ginghina C. Stoica AL, et al. J Vasc Surg. 2010 Jul;52(1):103-9. doi: 10.1016/j.jvs.2010.01.088. Epub 2010 Apr 10. J Vasc Surg. 2010. PMID: 20385468 - Prognostic Value of Flow-Mediated Vasodilation in Brachial Artery and Fingertip Artery for Cardiovascular Events: A Systematic Review and Meta-Analysis.
Matsuzawa Y, Kwon TG, Lennon RJ, Lerman LO, Lerman A. Matsuzawa Y, et al. J Am Heart Assoc. 2015 Nov 13;4(11):e002270. doi: 10.1161/JAHA.115.002270. J Am Heart Assoc. 2015. PMID: 26567372 Free PMC article. Review. - [Brachial arterial flow mediated dilation: utility in clinical and experimental practice].
Santos-García D, Rodríguez-Yáñez M, Arias-Rivas S, Blanco M. Santos-García D, et al. Rev Neurol. 2011 Sep 16;53(6):351-60. Rev Neurol. 2011. PMID: 21894606 Review. Spanish.
Cited by
- Multi-modality imaging for assessment of the microcirculation in peripheral artery disease: Bench to clinical practice.
Callegari S, Feher A, Smolderen KG, Mena-Hurtado C, Sinusas AJ. Callegari S, et al. Am Heart J Plus. 2024 May 8;42:100400. doi: 10.1016/j.ahjo.2024.100400. eCollection 2024 Jun. Am Heart J Plus. 2024. PMID: 38779485 Free PMC article. - Age and sex differences in microvascular responses during reactive hyperaemia.
Citherlet T, Raberin A, Manferdelli G, Mota GR, Millet GP. Citherlet T, et al. Exp Physiol. 2024 May;109(5):804-811. doi: 10.1113/EP091652. Epub 2024 Mar 20. Exp Physiol. 2024. PMID: 38509637 Free PMC article. - Sitting leg vasculopathy: potential adaptations beyond the endothelium.
Ferreira-Santos L, Martinez-Lemus LA, Padilla J. Ferreira-Santos L, et al. Am J Physiol Heart Circ Physiol. 2024 Mar 1;326(3):H760-H771. doi: 10.1152/ajpheart.00489.2023. Epub 2024 Jan 19. Am J Physiol Heart Circ Physiol. 2024. PMID: 38241008 Review. - Ultrasonographic assessment of brachial artery reactivity as a predictor of adverse outcome in patients undergoing emergency laparotomy for perforated peritonitis - Prospective observational study.
Ravikumar RH, Maitra S, Prasanna M, Anand RK, Bansal VK, Baidya DK. Ravikumar RH, et al. Indian J Anaesth. 2023 Oct;67(10):905-912. doi: 10.4103/ija.ija_625_23. Epub 2023 Oct 16. Indian J Anaesth. 2023. PMID: 38044920 Free PMC article. - Overexpression of Human Soluble Epoxide Hydrolase Exacerbates Coronary Reactive Hyperemia Reduction in Angiotensin-II-Treated Mouse Hearts.
Hanif A, Edin ML, Zeldin DC, Nayeem MA. Hanif A, et al. J Cardiovasc Pharmacol. 2024 Jan 1;83(1):46-54. doi: 10.1097/FJC.0000000000001490. J Cardiovasc Pharmacol. 2024. PMID: 37788350
References
- Loscalzo J, Vita JA. Ischemia, hyperemia, exercise, and nitric oxide: Complex physiology and complex molecular adaptations. Circulation. 1994;90:2556–2559. - PubMed
- Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P, Creager MA. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol. 1996;270:H1435–H1440. - PubMed
- Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Kajiyama G, Oshima T. A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans. Am J Cardiol. 2001;87:121–125. - PubMed
- Mitchell GF, Parise H, Vita JA, Larson MG, Warner E, Keaney JF, Jr, Keyes MJ, Levy D, Vasan RS, Benjamin EJ. Local shear stress and brachial artery flow-mediated dilation: The Framingham Heart Study. Hypertension. 2004;44:134–139. - PubMed
- Vita JA, Keaney JF, Jr, Larson MG, Keyes MJ, Massaro JM, Lipinska I, Lehman B, Fan S, Osypiuk E, Wilson PWF, Vasan RS, Mitchell GF, Benjamin EJ. Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation. 2004;110:3604–3609. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 HL075795/HL/NHLBI NIH HHS/United States
- R01 HL075795-02/HL/NHLBI NIH HHS/United States
- R01 HL083269-01A1/HL/NHLBI NIH HHS/United States
- R01 HL083269-03/HL/NHLBI NIH HHS/United States
- P50 HL083801-020001/HL/NHLBI NIH HHS/United States
- T32 HL007224/HL/NHLBI NIH HHS/United States
- K12 HL083781-01/HL/NHLBI NIH HHS/United States
- P01 HL081587-040005/HL/NHLBI NIH HHS/United States
- P01 HL081587-020005/HL/NHLBI NIH HHS/United States
- HL55993/HL/NHLBI NIH HHS/United States
- P50 HL055993/HL/NHLBI NIH HHS/United States
- P50 HL083801/HL/NHLBI NIH HHS/United States
- R01 HL083269/HL/NHLBI NIH HHS/United States
- HL60886/HL/NHLBI NIH HHS/United States
- K12 HL083781-02/HL/NHLBI NIH HHS/United States
- P50 HL083801-01/HL/NHLBI NIH HHS/United States
- K12 HL083781/HL/NHLBI NIH HHS/United States
- P50 HL083801-010001/HL/NHLBI NIH HHS/United States
- HL083781/HL/NHLBI NIH HHS/United States
- HL75795/HL/NHLBI NIH HHS/United States
- P50 HL083801-017464/HL/NHLBI NIH HHS/United States
- R01 HL083269-02/HL/NHLBI NIH HHS/United States
- P01 HL081587/HL/NHLBI NIH HHS/United States
- R01 HL075795-05/HL/NHLBI NIH HHS/United States
- P50 HL083801-030001/HL/NHLBI NIH HHS/United States
- R01 HL075795-01/HL/NHLBI NIH HHS/United States
- P50 HL083801-02/HL/NHLBI NIH HHS/United States
- P01 HL060886/HL/NHLBI NIH HHS/United States
- R01 HL075795-03/HL/NHLBI NIH HHS/United States
- HL 083269/HL/NHLBI NIH HHS/United States
- P01 HL081587-030005/HL/NHLBI NIH HHS/United States
- P50 HL083801-03/HL/NHLBI NIH HHS/United States
- T32 HL 07224/HL/NHLBI NIH HHS/United States
- P01 HL081587-010005/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources